Nitric oxide targets bronchiolar epithelial cells in murine cytomegalovirus-associated disease in lungs that are free of the virus

Archives of Virology

Volumn 146, Issue 8, 2001, Pages 1499-1515

  Tanaka, K ^a   Noda, S ^a   Sawamura, S ^a   Kabir, A M A ^a   Koga, Y ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL STIMULATION; CONCENTRATION (PARAMETERS); EPITHELIUM CELL; HISTOCHEMISTRY; INJECTION; LUNG; MORTALITY; MURINE CYTOMEGALOVIRUS; NITRIC OXIDE; STAPHYLOCOCCUS ENTEROTOXIN B; T LYMPHOCYTE; TISSUE DISTRIBUTION; VIRUS DETECTION; VIRUS DNA; VIRUS INFECTION;

ANIMALS; ANTIBODIES; ANTIGENS, CD3; BRONCHI; HERPESVIRIDAE INFECTIONS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MUROMEGALOVIRUS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PNEUMONIA, VIRAL; RESPIRATORY MUCOSA; TYROSINE;

EID: 0034862688     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050170074     Document Type: Article

References (42)

1. Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2)
2. Pathogenesis of influenza virus-induced pneumonia: Involvement of both nitric oxide and oxygen radicals
3. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells
4. Lungs are a major organ site of cytomegalovirus latency and recurrence
5. Nitric oxide and lung disease
6. Cytomegalovirus
7. Enzymic mechanisms of superoxide production
8. The role of peroxynitrite in nitric oxide-mediated toxicity
9. Enhanced HIV-1 replication in Vβ12 T cells due to human cytomegalovirus in monocytes: Evidence for a putative herpesvirus superantigen
10. Clinical insights and observations contributing to the understanding of cytomegalovirus disease pathogenesis. Bone marrow transplantation
11. Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?
12. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo
13. Interferon-γ and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators
14. Viral diseases
15. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells
16. Inhaled nitric oxide reduces tyrosine nitration after lipopolysaccharide instillation into lungs of rats
17. Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice
18. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients
19. Evidence for in vivo peroxynitrite production in human acute lung injury
20. Host immune response to cytomegalovirus: Products of transfected viral immediate-early genes are recognized by cloned cytolytic T lymphocytes
21. Latency versus persistence or intermittent recurrences: Evidence for a latent state of murine cytomegalovirus in the lungs
22. High incidence of active cytomegalovirus infection among septic patients
23. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line
24. Altered response to bacterial infection and endotoxin shock in mice lacking inducible nitric oxide synthetase
25. Nitric oxide and macrophage function
26. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation
27. Airway epithelial cells, cytokines, and pollutants
28. Enhanced (cytomegalovirus) viral replication associated with septic bacterial complications in liver transplant recipients
29. Inducible nitric oxide synthase: What difference does it make?
30. Role of NO synthase Type2 in acute infection with murine cytomegalovirus
31. Nitric oxide increases the amount of murine cytomegalovirus-DNA in mice latently infected with the virus
32. Treatment of cytomegalovirus pneumonia with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine and high-dose corticosteroids
33. Expression of inducible nitric oxide in human lung epithelial cells
34. Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation
35. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis
36. Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia
37. Murine cytomegalovirus-associated pneumonitis in the lungs free of the virus
38. Nitric oxide mediates murine cytomegalovirus-associated pneumonitis in lungs that are free of the virus
39. The Vβ-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice
40. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages
41. Pathogenesis of CMV-associated diseases in 1990
42. Cytomegalovirus infection